Waist-to-Hip Ratio Is Positively Associated with Bioavailable Testosterone but Negatively Associated with Sexual Desire in Healthy Premenopausal Women by van Anders, Sari M. & Hampson, Elizabeth
Waist-to-Hip Ratio Is Positively Associated With Bioavailable Testosterone but
Negatively Associated With Sexual Desire in Healthy Premenopausal Women
SARI M. VAN ANDERS, MA, AND ELIZABETH HAMPSON, PHD
Objective: We examined whether high waist-to-hip ratio (WHR) in women is a biomarker for increased testosterone (T) and higher
levels of sexual desire. Methods: Participants were 99 healthy nonobese premenopausal women. Trait levels of mean bioavailable
T were estimated from three saliva samples collected at 8:00 AM, 9:30 AM, and 6:00 PM to 9:00 PM, controlling for phase of the
menstrual cycle. Sexual desire was measured with the Sexual Desire Inventory. Results: WHR was positively, although moderately,
correlated with bioavailable T. WHR, but not T, was negatively correlated with level of sexual desire. Conclusions: These results
confirm that the positive association between WHR and androgens seen in clinical populations also exists in the general population
of healthy adult women. However, the relationship may not be strong enough in healthy women for WHR to serve as a useful
biomarker of androgen levels in sexuality studies, especially given its association with other, perhaps negatively valued,
morphologic attributes. Key words: testosterone, waist-to-hip ratio, sexual desire, central fat deposition, saliva radioimmunoassay.
BMI  body mass index; T  testosterone; WHR  waist-to-hip
ratio; HPA  hypothalamic–pituitary–adrenal axis; CNS  central
nervous system; SDI  Sexual Desire Inventory.
INTRODUCTION
Research concerning WHR (the ratio of waist to hip circum-ference) in women has focused largely on its value as a
biomarker for health and attractiveness. Men and women in
various Western cultures rate low WHR ratios as more sexu-
ally attractive in women (1–3). This preference has ecologic
validity because higher ratios (eg, 0.80) are associated with
various adverse factors. For example, women with high WHR
exhibit decreased fertility (4,5), more menstrual irregularities
(6) and cardiovascular disease risk factors (6–8), less physical
activity (9), higher levels of anger, anxiety, depression, lower
levels of social support (7) and education (9), more stress, a
greater stress reactivity (10), and more unemployment prob-
lems (9). Some researchers have speculated that hypothalam-
ic–pituitary–adrenal (HPA) hyperactivity may be present in
some high WHR women (10), although androgens have been
most consistently implicated in high WHR values.
An association between high androgen levels and high
WHR has been found in postmenopausal women (11 cf. 12),
women with androgen excess (13), obese adolescent girls (14)
and women (15,16), female-to-male transsexuals (17), and in
women of differing sexual orientations (18). Evidence from
female-to-male transsexuals suggests that testosterone treat-
ment increases visceral fat in the abdomen but not hip (19),
which would lead to higher WHR. The cellular mechanisms
by which androgens cause differential fat deposition and in-
creased WHR are currently not well understood.
Besides exerting effects on peripheral target tissues, circu-
lating androgens affect target neural systems that mediate
behavior (20), including, possibly, sexual desire. The etiology
of sexual desire is multifaceted, but androgens seem to exert
influence (21,22). Women with low androgens experience a
loss of sexual desire (23,24). Testosterone administration ap-
pears to be effective at alleviating complaints of low sexual
desire (25,26) and increases sexual desire in female-to-male
transsexuals (27). However, WHR tends to be positively as-
sociated with body mass index (BMI), and some data suggest
that BMI correlates negatively with sexual desire in women
(28). The authors suggested that women with higher BMIs
might feel more negative about their bodies, overwhelming
any hormonal influences on sexual desire.
Two main hypotheses were tested in the present study. The
first was that WHR would be positively correlated with sali-
vary testosterone in a group of healthy young women. The
second hypothesis was that WHR would significantly predict
individual differences in sexual desire.
METHODS
Subjects
Subjects were 99 female volunteers (mean age, 23.76 years; standard
deviation [SD], 5.66; range, 18–42 years) from the University of Western
Ontario recruited through newspaper ads and posters on campus. A reim-
bursement was offered. The notices advised that women of all body types who
were healthy, between the ages of 18 and 40 years, not using hormonal
contraceptives, and not pregnant or breastfeeding were welcome to partici-
pate. It also stated that measures of fat deposition and sexual desire would be
collected. Participants may therefore represent a self-selected sample of
women comfortable enough to have such measures taken. Not all women who
contacted the experimenter agreed to participate, but this was mostly the result
of a dislike of the 8:00 AM testing time.
The majority of the 99 participants were single (n  63), whereas 20
women were in monogamous relationships and 14 were married or cohabiting
(no response from two women). Participants were mostly university students
(n  83). The sample was predominantly heterosexual with only four women
scoring 3 or more on the Kinsey items of sexual fantasy and experience (29).
The vast majority of women (n  94) had menstrual cycles between 24 and
34 days in length that varied by 1 to 7 days (n  90).
A mean testosterone (T) value for each woman was computed from three
saliva samples (see subsequently). Four women had T levels greater than three
SDs from the mean, likely reflecting trace blood contamination in the saliva.
These women were excluded from all statistical analyses involving T. An
additional four women were missing one of the three saliva samples and a
mean T value could not be computed. One woman with a WHR over three
standard deviations from the mean also was eliminated. Therefore, 90 women
were included in the T analyses.
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Procedure
Testing took place in the first 7 days of the menstrual cycle, when steroid
hormones are relatively stable. Sessions began at 8:00 AM, when T levels are
high (30), and lasted approximately 1.5 hours. Saliva samples were collected
at the beginning and end of the test session, as well as between 6:00 PM and
9:00 PM when T levels are low (31). The evening sample was collected in the
participants’ homes. Saliva was chosen for ease of collection and because it
is the free or weakly bound steroid that is represented in saliva (32). The times
were selected to include the full range of diurnal variation in T.
During the early morning session, measures of mood, cognitive abilities,
sexual desire and orientation, health and demographics, and physique were
taken. Cognitive data will be the subject of a separate report.
Sexual Desire Inventory
Participants completed the Sexual Desire Inventory (SDI) (33), standard-
ized to an 8-point scale. The SDI was adapted by the addition of one question:
“During the last month, how often have you had sexual thoughts?” Sexual
desire represents the appropriate construct for our study because it is relatively
independent of partner availability and because previous research has linked
it to circulating hormones. The adapted SDI consisted of 15 questions.
Subjects indicated the strength and frequency of sexual desire over the past
month on an 8-point scale that ranged from “no desire” to “strong desire.” The
inventory provided a total SDI score and two subscales: dyadic SDI and
solitary SDI.
The SDI has test–retest reliability over 1 month of 0.76 (34). It has been
validated as a measure of sexual desire in psychologic studies (33,35,36) and
endocrine studies (26).
Control Tests
Subjects completed the Profile of Mood States (POMS) (37), which
assesses self-reported mood. There is evidence for an association between
negative mood states and high WHR (10). Subjects rated the degree to which
65 emotional adjectives described their characteristic mood state within the
past week. Each item is responded to on a 5-point scale ranging from “not at
all” to “extremely.” The total mood disturbance score was calculated (POMS-
TMD).
Finally, a health and background questionnaire was given to collect
information concerning demographic, health, or experiential factors that could
influence the sexual desire or T findings.
Anthropometric Measures
Height (in centimeters) and weight (in kilograms) (Health-o-Meter, Sun-
beam Products Inc., Bridgeview, IL) were measured by a single experimenter
to calculate BMI. Waist circumference was measured to the nearest 0.5 cm
against the skin at the narrowest point between the chest and hips. Hip
circumference was measured to the nearest 0.5 cm against the skin or
underwear at the widest point around the hips and buttocks; in a small
minority of cases, because of modesty, the hip measurement was done over a
towel draped over the hips. In these cases, 2.5 cm was deducted from the
measured circumference. (Hip measurements were taken from 20 women both
with and without the towel to establish a correction factor. The mean differ-
ence between hip-with-towel and hip-without-towel measurements was 2.54
[SD  1.59].) All four measures were taken twice for greater reliability. The
WHR consisted of the mean of the two waist measures divided by the mean
of the two hip measures.
Skinfold thicknesses were taken in triplicate to further assess the relation
between T and sex-typical fat deposition. Calipers (SlimGuide Calipers;
Creative Health Products, Plymouth, MI) were used at five sites on the body’s
right side. The calipers were accurate to 0.5 mm. A kinesiologist trained the
experimenter. The tricep, subscapula, and thigh were selected to assess
peripheral fat deposition, whereas the iliac crest and abdomen represented
central fat deposition. The score for each site was the mean of the two closest
measurements or of all three with equidistant measures.
Saliva Collection
To optimize the quality of the saliva, subjects were asked not to eat, drink
(except plain water), smoke, or brush their teeth for 1 hour before collection.
The mouth was rinsed with water and an inert sugar-free gum was provided
to stimulate saliva flow. The saliva was collected in a polystyrene culture tube
pretreated with sodium azide. After collection, tubes were kept covered at
room temperature for 18 to 24 hours to allow separation to occur. The tubes
were then stored at 20°C until analysis.
Radioimmunoassays
Specimens were thawed at 4°C and centrifuged at 3000 rpm for 15
minutes. A double ether extraction was then performed. As a result of the
large number of specimens, the assay was done in two batches, each using a
single Coat-a-Count kit for total testosterone (Diagnostic Products Corp., Los
Angeles, CA) modified for use with saliva. Of 10 immunoassay kits evaluated
in a recent study, the DPC kit was found to yield the best correlation with a
gas chromatography/mass spectrometry measure of T in women (38). All
specimens were assayed in duplicate. The sensitivities were 2.5 pg/mL for
both assays, and the intraassay coefficients of variation were 4% and 9%. The
antiserum used is highly specific to testosterone with negligible crossreactiv-
ity with other steroids except dihydrotestosterone (3.5%). Values used for
statistical analysis were the mean testosterone concentrations across the two
duplicates.
To ensure the samples showed the expected diurnal pattern of high
morning and low evening T (31,39), a repeated-measures analysis of variance
was performed. As expected, there was a significant difference among the
three samples (F[2,180]  93.44, p .001), and post hoc tests using Fisher’s
least significant difference (LSD) test showed that all samples differed sig-
nificantly from each other in the expected direction: 8:00 AM (mean, 22.09
pg/mL; SD, 6.28), 9:30 AM (mean, 17.10 pg/mL; SD, 4.52), 6:00 PM to 9:00
PM (mean, 14.42 pg/mL; SD, 5.01).
RESULTS
Testosterone and Waist-to-Hip Ratio
The first hypothesis was that WHR would be a significant
predictor of individual differences in T. WHR values ranged
from 0.66 to 0.87. As predicted, WHR was positively corre-
lated with T (Pearson’s r [88]  0.35, p  .001, Figure 1). The
size of the relationship was modest. With age, T declines in
women (21) and WHR tends to increase (40) because estrogen
shows a more striking reduction than T. As well, high BMI
Figure 1. Scatterplot of the relationship between waist-to-hip ratio and mean
testosterone (pg/mL).
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can be associated with high T (14) and high WHR (41). To
determine whether age and BMI were concealing the strength
of the correlation between WHR and T, partial correlations
were computed controlling for these variables (12). BMIs
ranged from 16.1 to 34.4. The partial correlation between
WHR and T, controlling for age and BMI, was significant
(partial r [83]  0.37, p  .001). Thus, WHR was positively
correlated with bioavailable T independent of variation in
women’s body mass.
To further clarify androgenic associations with WHR, sep-
arate correlations were conducted between T and waist, and T
and hip. Neither hip circumference (r [88]  0.09, p  .410)
nor waist circumference (r [88]  0.11, p  .305) was
correlated with T. This emphasizes that the ratio is important,
not absolute body size.
Skinfold thickness, a measure of local fat deposition, was
also evaluated (see Table 1 for all sites). Only the central-
abdominal sites showed significant correlations between T
and skinfold thickness: abdominal site (r [88]  0.22, p 
.040) and the iliac crest (r [88]  0.21, p  .044). Therefore,
high T was selectively related to increased central fat deposi-
tion, supporting the high T–high WHR relationship.
To examine whether the WHR–T correlation translated into
a group difference, women were divided into two WHR
groups using a median split: low WHR (mean, 0.73; SD, 0.02;
n  49) and high WHR (mean, 0.79; SD, 0.03; n  49). An
independent samples t test confirmed that the low WHR group
had significantly lower mean T (mean, 16.47; SD, 3.64) than
the high WHR group (mean, 19.35; SD, 4.52) (t[83]  3.32,
p  .001, two-tailed).
Thus, the group results and the correlations indicated that
WHR was positively correlated with bioavailable testosterone.
Waist-to-Hip Ratio and Sexual Desire
The second hypothesis was that WHR would be positively
correlated with sexual desire. Sexual desire was assessed
using the SDI (33). The internal consistencies of the two SDI
subscales and the total SDI scale were estimated using Cron-
bach’s alpha and showed excellent reliability with coefficients
of: SDI total  0.90, SDI dyadic  0.89, and SDI solitary 
0.91. Thus, each scale appeared to be reliably measuring its
designated construct. Single and partnered women did not
differ significantly in SDI dyadic (r [81]  1.41, p  .162).
Women who were using psychoactive medications or who
had a psychiatric or neurologic condition (n  14) were
excluded from these analyses. This was done to avoid con-
founds from the dampening effects of various drugs on libido.
Contrary to prediction, neither SDI total (r [82]  0.16,
p  .160), SDI solitary (r [82]  0.14, p  .212), nor SDI
dyadic (r [82]  0.08, p  .455) was significantly correlated
with WHR. Because previous work has suggested that nega-
tive affect, BMI (7,9,29), and age (23,42) may covary with
WHR and sexual desire, partial correlations were computed.
The partial correlation, with age, BMI, and POMS-TMD
removed, between WHR and SDI total was significant but
negative (partial r [76]  0.23, p  .047), and the partial
correlation between WHR and SDI solitary approached sig-
nificance (partial r [76]  0.21, p  .060). These results
indicate that WHR and sexual desire were not positively
correlated and, if anything, were negatively correlated.
The basis for expecting an association between sexual
desire and WHR was that sexual desire would be positively
correlated with T. However, there were no significant corre-
lations between mean T and the SDI scores (all r’s 0.10;
N  76), nor were there any significant partial correlations
when the effects of BMI, age, and POMS-TMD were ex-
cluded: SDI total (partial r [69]  0.04, p  .729), SDI
dyadic (partial r [69]  0.10, p  .410), SDI solitary
(partial r [69]  0.05, p  .696). These results indicate that
T was not correlated with sexual desire.
To summarize, the results showed support for the first
hypothesis. WHR was a visible biomarker of bioavailable T.
High WHR was associated with high T. The other hypothesis
was not supported. We failed to find evidence that increased
WHR is a marker of increased sexual desire.
DISCUSSION
In the present study, T was within the expected range at
each sampling time point (26,43,44) and showed the expected
diurnal pattern (31,39). Thus, the T levels in our sample
showed no aberrations that would limit the generalizability of
our conclusions.
As predicted, WHR was significantly and positively corre-
lated with bioavailable T. This correlation presumably repre-
sents the actions of long-term trait levels of T that differ
reliably across individuals. As well, the skinfold thicknesses
representing central but not peripheral measures of fat depo-
sition were significantly and positively correlated with T.
Thus, in our data, T was uniquely associated with measures of
central fat, and not merely fat deposition at any location.
Other research has shown positive associations between T
and WHR in special populations, including women with an-
drogen excess (13), self-identified “butch” lesbians (18), post-
menopausal women (11), female-to-male transsexuals (17),
and obese women (16,45). To our knowledge, the present
study is the first study to illustrate a relationship between
bioavailable T and WHR in healthy adult premenopausal
women. The size of the correlation (r  0.37) compares
favorably with the correlations found in clinical populations,
TABLE 1. Pearson’s Product-Moment Correlations Between










Iliac crest 0.21* 0.19†
*p .05.
†p .10.
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which range from 0.22 to 0.55. However, the modest size of
the correlation between T and WHR probably precludes its
use as a biomarker for T in sexuality studies. High WHR does
appear to be a useful biomarker for health variables (eg,
(4,5,7,8)) and attractiveness (eg, (1)).
Contrary to our prediction, there was no evidence that high
WHR is a biomarker for increased sexual desire. Instead, we
found a significant negative association. Our failure to find a
positive association is understandable because the expected
underlying positive relationship between T and sexual desire
was not present. Evidence certainly points to a positive asso-
ciation between T and sexual desire in women, but this evi-
dence stems almost entirely from clinical studies (25,26,46).
Our large sample size suggests other explanations. It may be
that in healthy adult women, the range of T is truncated and
too small for associations between sexual desire and T to be
found. Another possibility is that only increases in T from
some earlier stable baseline are associated with increases in
sexual desire; or, the influence of hormones on sexual desire
in healthy premenopausal women may be diluted by other
factors (eg, (28,47)) because the etiology of sexual desire is
multifaceted (22). We found sexual desire to be negatively
correlated with WHR. This agrees with some prior evidence
(47) and may be the result of factors other than T.
To our knowledge, this is the first study to provide evi-
dence for a positive association between WHR and bioavail-
able T in healthy premenopausal adult women. It increases our
understanding of how WHR is related to physiological and
endocrine states, and suggests that increased tissue exposure
to unbound androgens may predispose normal-weight women
to accumulate fat in a male-typical upper body distribution. A
positive association with sexual desire could not be demon-
strated.
The authors thank Mrs. Bavani Rajakumar for doing the hormone
radioimmunoassays. This article is based on master’s thesis research
by Sari M. van Anders at the University of Western Ontario. She is
now at Simon Fraser University.
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